Funding of just under £50k from IBioIC enabled Ingenza to gain invaluable expertise and enhanced their ability to access new markets and end users thanks to the technology developed as a result of this project.

Scientists at the University of Bristol discovered a probiotic strain of Streptococcus thermophilus which had been found to have a variety of health benefits. Unfortunately, the media on which it was grown rendered it unsuitable for human consumption. Our Technical Team were approached to develop a new media which would provide similar cell growth and facilitate a commercially viable product.